
mRNA therapy shows promise for maple syrup urine disease
Researchers from the University of Pennsylvania, Perelman School of Medicine, Gene Therapy Program, and Moderna, have shown that repeated administration of lipid nanoparticle-encapsulated mRNA therapy significantly extended survival and reduced serum leucine levels in a mouse model of maple syrup urine disease (MSUD).
Share
Facebook
X
LinkedIn
Telegram
Tumblr
Whatsapp
VK
Mail